pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Application of Cognitive Training Based on Remind Strategy in Glioma Patients With Cognitive Impairment
Status: RECRUITING
Conditions: Glioma
Interventions: OTHER: Individual cognitive rehabilitation training based on Remind strategy was given
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke
Status: RECRUITING
Conditions: Stroke|PET|Thrombosis
Interventions: DIAGNOSTIC_TEST: 18F-GP1 PET/CT|DIAGNOSTIC_TEST: Agitated Contrast Echocardiogram|DIAGNOSTIC_TEST: MRI Head|DIAGNOSTIC_TEST: ECG Monitoring
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin
Status: COMPLETED
Conditions: Type 2 Diabetic Patients|Insufficient Metabolic Control|OAD Treatment
Interventions: DRUG: Insulin Glargin|DRUG: NPH insulin|DRUG: Insulin detemir|DRUG: metformin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve
Status: UNKNOWN
Conditions: Endometriosis
Interventions: PROCEDURE: laparoscopic ovarian endometriotic cyst
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: CyberKnife Radiosurgery for Localized Prostatic Carcinoma
Status: UNKNOWN
Conditions: Prostate Cancer
Interventions: RADIATION: CyberKnife Radiosurgery|RADIATION: CyberKnife Radiosurgery
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Therapy
Status: UNKNOWN
Conditions: Esophageal Squamous Carcinoma
Interventions: DRUG: JMT101|DRUG: Afatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
Status: COMPLETED
Conditions: Stage 0 Skin Melanoma|Stage I Skin Melanoma|Stage IA Skin Melanoma|Stage IB Skin Melanoma|Stage II Skin Melanoma|Stage IIA Skin Melanoma|Stage IIB Skin Melanoma|Stage IIC Skin Melanoma|Stage III Skin Melanoma|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma
Interventions: OTHER: Internet-Based Intervention|OTHER: Questionnaire Administration|OTHER: Survey Administration
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
Status: COMPLETED
Conditions: Vitamine K Antagonist (VKA) Treatment|International Normalized Ratio (INR) Measure at Home|Thromboembolic Pathology
Interventions: DEVICE: LabPad® point-of-care
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA
Status: COMPLETED
Conditions: Rheumatoid Arthritis
Interventions: BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes
Status: COMPLETED
Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: DRUG: sulforaphane|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion
Status: RECRUITING
Conditions: Retinal Vein Occlusion|Macular Edema
Interventions: DRUG: Ranibizumab 0.5 MG/0.05 ML Intraocular Solution [LUCENTIS]|DEVICE: Ultra-wide Fluorescein Angiography
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin
Status: TERMINATED
Conditions: Hepatitis C
Interventions: DRUG: Infergen and ribavirin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine
Status: COMPLETED
Conditions: Pertussis|Whooping Cough
Interventions: BIOLOGICAL: BPZE1|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Status: UNKNOWN
Conditions: Lung Cancer
Interventions: DRUG: cisplatin|DRUG: gefitinib|DRUG: gemcitabine hydrochloride
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC
Status: COMPLETED
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: ENMD-2076
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Sub-Occipital Myofascial Release in Patients With Cervicogenic Headache
Status: COMPLETED
Conditions: Cervicogenic Headache
Interventions: OTHER: cervical mobilization (Headache SNAG)|OTHER: Sub-occipital myofascial release
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies
Status: COMPLETED
Conditions: Graft vs Host Disease|Hematologic Neoplasms|Lymphoma|Myelodysplastic Syndromes|Myeloid Leukemia
Interventions: PROCEDURE: Peripheral blood progenitor cell transplant
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Respiratory Drive on Obstructive Apnea
Status: TERMINATED
Conditions: Obstructive Sleep Apnea
Interventions: DEVICE: Rebreathing bag|DEVICE: Sham rebreathing|DEVICE: Mask
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: COMPLETED
Conditions: Ocular Hypertension|Glaucoma
Interventions: DRUG: AGN-210669 ophthalmic solution, 0.075%|DRUG: AGN-210669 ophthalmic solution, 0.05%|DRUG: AGN-210669 ophthalmic solution, 0.025%|DRUG: bimatoprost ophthalmic solution 0.03%|DRUG: AGN-210669 vehicle ophthalmic solution
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
Status: TERMINATED
Conditions: Autosomal-dominant Hyper-IgE Syndrome
Interventions: DRUG: NDV-3A
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Bevacizumab in Treating Patients With Myelodysplastic Syndrome
Status: COMPLETED
Conditions: Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
Interventions: BIOLOGICAL: bevacizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy
Status: ACTIVE_NOT_RECRUITING
Conditions: Liver Metastasis|Colorectal Cancer|Metastasis
Interventions: PROCEDURE: Liver Transplantation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of DHEA on Patients With Poor Ovarian Responds
Status: RECRUITING
Conditions: Subfertility
Interventions: DRUG: Dehydroepiandrosterone|OTHER: placebo(medical starch)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects
Status: COMPLETED
Conditions: Aneurysmal Subarachnoid Hemorrhage
Interventions: DRUG: GTX-104|DRUG: Nimodipine Capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Speed Endurance Training, Muscle Damage and Performance in Soccer Players
Status: COMPLETED
Conditions: Speed Endurance Training Protocol 1|Speed Endurance Training Protocol 2|Control
Interventions: OTHER: Speed endurance training protocol A|OTHER: Speed endurance training protocol B
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Status: COMPLETED
Conditions: Safety and Tolerability
Interventions: DRUG: K-312|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose:
Clinical trial: Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion
Status: COMPLETED
Conditions: HELICOBACTER INFECTION
Interventions: BIOLOGICAL: Pylopass|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis
Status: COMPLETED
Conditions: Hemolytic Uremic Syndrome|Hemorrhagic Colitis|Intestinal Infectious Disease|Intestinal Infection Due to E. Coli
Interventions: DRUG: polyethylene glycol solution for daily bowel lavage.
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars
Status: UNKNOWN
Conditions: Pulpitis|Dental Pulp Disease|Tooth Diseases
Interventions: DRUG: Formocresol|DRUG: Mineral Trioxide Aggregate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis
Status: NOT_YET_RECRUITING
Conditions: Lupus Nephritis
Interventions: BIOLOGICAL: Umbilical cord mesenchymal stem cells|DRUG: Normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: A P300 Brain Computer Interface to Operate Power Wheelchair Tilt
Status: COMPLETED
Conditions: Healthy|Amyotrophic Lateral Sclerosis
Interventions: DEVICE: Using a BCI to control wheelchair tilt
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
Status: RECRUITING
Conditions: Triple Negative Breast Cancer|Hormone Receptor Positive (HR+), HER2-negative Breast Cancer|Biopsy-proven, Positive Lymph Node(s)
Interventions: RADIATION: Radiation Therapy Boost|DRUG: Pembrolizumab|DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Cyclophosphamide|DRUG: Doxorubicin|DRUG: Capecitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Technical Feasibility of Routine Intraoperative Cholangiography During Elective Rigid-hybrid Transvaginal Natural Orifice Transluminal Endoscopic Cholecystectomy
Status: COMPLETED
Conditions: Gallstone Disease
Interventions: PROCEDURE: Cholangiography during transvaginal rigid-hybdrid NOTES cholecystectomy
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle Loss
Status: NOT_YET_RECRUITING
Conditions: Osteoporosis Risk|Bone Loss
Interventions: DEVICE: HR-pQCT|DEVICE: pQCT|DEVICE: DEXA
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Pembro Plus CAR T-cell Therapy in R/R in PMBCL
Status: RECRUITING
Conditions: Primary Mediastinal Large B-cell Lymphoma (PMBCL)|Primary Mediastinal Large B Cell Lymphoma|Primary Mediastinal Large B-Cell Lymphoma Refractory|Primary Mediastinal Large B-Cell Lymphoma Recurrent|Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma|T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Interventions: DRUG: Pembrolizumab|DRUG: Lymphodepletion Chemotherapy|DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion|PROCEDURE: Leukapheresis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation
Status: COMPLETED
Conditions: Kidney Diseases|Kidney Failure, Chronic|Kidney Failure|Renal Insufficiency|Renal Insufficiency, Chronic|Urologic Diseases
Interventions: DEVICE: remote ischaemic preconditioning
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS
Status: UNKNOWN
Conditions: Adult Acute Myeloid Leukemia in Remission
Interventions: BIOLOGICAL: Alloreactive NK cell infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
Status: RECRUITING
Conditions: Influenza|Influenza, Human
Interventions: DRUG: Oseltamivir|DRUG: Favipiravir|DRUG: Zanamivir|DRUG: Baloxavir|DRUG: Molnupiravir|DRUG: Peramivir|DRUG: Laninamivir|DRUG: Oseltamivir and Baloxavir|DRUG: Oseltamivir and Favipiravir|DRUG: Favipiravir and Baloxavir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion
Status: COMPLETED
Conditions: IUD Insertion Pain
Interventions: DRUG: Isosorbide mononitrate|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Pallidotomy in the Treatment of Dyskinesia of Parkinson's Disease
Status: COMPLETED
Conditions: Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
Interventions: DEVICE: transcranial magnetic resonance guided focused ultrasound pallidotomy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
Status: ACTIVE_NOT_RECRUITING
Conditions: Acute Promyelocytic Leukemia With PML-RARA|t(15;17)
Interventions: OTHER: Best Practice|OTHER: Laboratory Biomarker Analysis|PROCEDURE: Supportive Care
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Perception-Action Approach vs. Passive Stretching for Infants With Congenital Muscular Torticollis
Status: TERMINATED
Conditions: Congenital Muscular Torticollis
Interventions: BEHAVIORAL: Passive Stretching|BEHAVIORAL: Perception-Action Approach
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation
Status: RECRUITING
Conditions: Tricuspid Regurgitation
Interventions: DEVICE: Transcatheter Tricuspid Valve Implantation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: COMPLETED
Conditions: Urinary Incontinence|Nocturia
Interventions: BEHAVIORAL: Exercise-based behavioral therapy|BEHAVIORAL: Behavioral control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome
Status: COMPLETED
Conditions: Dry Eye Syndromes
Interventions: DEVICE: Thealoz Duo Gel and Thealoz Duo eye drops|DEVICE: Thealoz Duo eye drops
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: SUSPENDED
Conditions: Anti-coagulation Therapy|DVT|Pulmonary Embolism|Joint Surgery Multiple|Atrial Fibrillation|Prosthetic Replacement of Mitral Valve
Interventions: DEVICE: Warfarin GenoSTAT Test
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction
Status: NOT_YET_RECRUITING
Conditions: Parenteral Nutrition|Gastroparesis|Gastrointestinal Dysfunction|Protein Deficiency|Critical Illness
Interventions: DIETARY_SUPPLEMENT: Supplemental Parenteral Nutrition (SPN)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: DRUG: Ba 679 BR Respimat|DRUG: Tiotropium (Spiriva) inhalation capsule 18 ug
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks
Status: COMPLETED
Conditions: Chemotherapy|Anemia|Cancer
Interventions: DRUG: Epoetin alfa
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Omega-3 Fatty Acids on Outcome After Major Liver Resection
Status: UNKNOWN
Conditions: Major Liver Surgery
Interventions: DRUG: Omegaven™
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Remote Ischemic Preconditioning After Cardiac Surgery
Status: UNKNOWN
Conditions: Cardiac Surgery, Aortocoronary Bypass
Interventions: PROCEDURE: Remote ischemic preconditioning (RIPC)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Conditions: Advanced Solid Tumors
Interventions: DRUG: BMS-986213
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Irinotecan Liposome in Advanced Pancreatic Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Advanced Pancreatic Cancer
Interventions: DRUG: Irinotecan liposome；oxaliplatin；5-FU(Fluorouracil Injection)；LV(Calcium Folinate Injection)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Mobile Phone Application Versus Handheld Device for Fetal Vibroacoustic Stimulation
Status: TERMINATED
Conditions: Pregnancy
Interventions: DEVICE: Corometrics-146 device|DEVICE: Mobile phone application
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: PROCEDURE: Nasofibroscopy|OTHER: Low Dose Chest CTscan|OTHER: injected CT-scan|OTHER: whole body PET-CT|PROCEDURE: Lugol upper gastrointestinal endoscopy|PROCEDURE: Biopsy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers
Status: TERMINATED
Conditions: Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Esophageal Adenocarcinoma
Interventions: BIOLOGICAL: CRS-207|BIOLOGICAL: Pembrolizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
Status: ACTIVE_NOT_RECRUITING
Conditions: Metastatic Malignant Neoplasm in the Liver|Neuroendocrine Neoplasm
Interventions: PROCEDURE: Arterial Embolization|BIOLOGICAL: Pembrolizumab|BIOLOGICAL: Peptide Receptor Radionuclide Therapy (PRRT) using 177Lu-DOTA0-Tyr3-Octreotate|DEVICE: Yttrium-90 Microsphere Radioembolization
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
Status: COMPLETED
Conditions: Cardiac-induced Edema
Interventions: DRUG: Tolvaptan|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ultrathin DES in Complex PCI Scenarios: the ULTRA a Multicenter Study
Status: RECRUITING
Conditions: Coronary Artery Disease|Coronary Stenosis|Stent Restenosis|Left Main Coronary Artery Disease|Chronic Total Occlusion of Coronary Artery
Interventions: DEVICE: Percutaneous coronary intervention with the following platforms: Orsiro; Mistent; BioMime; Supraflex Cruz
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation
Status: NOT_YET_RECRUITING
Conditions: Endometrial Cancer
Interventions: DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Cisplatin|RADIATION: EBRT|RADIATION: VBT
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis
Status: WITHDRAWN
Conditions: Cystic Fibrosis
Interventions: DRUG: OligoG Dry powder for inhalation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ketamine and Postoperative Depressive Symptom-PASSION
Status: COMPLETED
Conditions: Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
Interventions: DRUG: Ketamine|DRUG: Normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Trial on an Educative Structured Intervention by Peer Educators to Improve HbA1c of Patients With Type 2 Diabetes in the Sikasso Region in Mali
Status: COMPLETED
Conditions: Type 2 Diabetes
Interventions: OTHER: Intensification of education
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: |Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents
Status: ACTIVE_NOT_RECRUITING
Conditions: HIV Infections
Interventions: DRUG: DTG + 3TC FDC
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Deep rTMS in Parkinson Disease Pain Syndromes
Status: UNKNOWN
Conditions: Pain|Parkinson Disease
Interventions: DEVICE: deep rTMS|DEVICE: placebo deep rTMS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
Status: COMPLETED
Conditions: Diabetes|Diabetes Mellitus, Type 2|Healthy
Interventions: DRUG: semaglutide|DRUG: semaglutide|DRUG: placebo|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Status: COMPLETED
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface|Malignant Peritoneal Mesothelioma|Peritoneal Carcinomatosis
Interventions: BIOLOGICAL: DC vaccine|DRUG: Celecoxib|DRUG: Interferon Alfa-2b|BIOLOGICAL: rintatolimod
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe
Status: COMPLETED
Conditions: Neovascular Age-related Macular Degeneration|Diabetic Macular Edema
Interventions: COMBINATION_PRODUCT: Faricimab PFS Configuration
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Resync-AF (Rate vs Rhythm Control in AF Patients With CRT-D)
Status: COMPLETED
Conditions: Atrial Fibrillation
Interventions: OTHER: rate control via CRT-D and AVN ablation|OTHER: rhythm control via pharmacologic, electrical or ablative therapies
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings
Status: UNKNOWN
Conditions: Urinary Stress Incontinence
Interventions: PROCEDURE: TVT-Abbrevo|PROCEDURE: Serasis
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution
Status: COMPLETED
Conditions: Contact Lens Wear
Interventions: DEVICE: ASP-57|DEVICE: ReNu® Multiplus
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Blueberry on Cognition and Mobility in Older Adults
Status: COMPLETED
Conditions: Aging|Age-Related Memory Disorders
Interventions: DIETARY_SUPPLEMENT: Freeze-dried Blueberry|DIETARY_SUPPLEMENT: Blueberry Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer
Status: COMPLETED
Conditions: Hereditary Breast and Ovarian Cancer Syndrome
Interventions: GENETIC: blood collection|GENETIC: blood collection
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Fractional Laser Drug Delivery of a Local Anesthetic
Status: COMPLETED
Conditions: Aging|Face; Atrophy
Interventions: PROCEDURE: Facial filler injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC
Status: RECRUITING
Conditions: Esophageal Squamous Cell Carcinoma
Interventions: RADIATION: Chemoradiotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetics of Two Formulations of Entecavir
Status: COMPLETED
Conditions: Hepatitis B
Interventions: DRUG: Entigin Film Coated Tablet 0.5mg|DRUG: (Baraclude 0.5mg Tablets
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
Status: COMPLETED
Conditions: Atopic Dermatitis
Interventions: DRUG: Pimecrolimus cream 1%|DRUG: cream 0.1% methylprednisolone aceponate
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Insulin icodec
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Efficacy and Safety of Interventions on the Pelvic Veins in Pelvic Venous Disorders
Status: COMPLETED
Conditions: Pelvic Venous Disorders|Pelvic Congestive Syndrome|May-Thurner Syndrome
Interventions: PROCEDURE: Gonadal veins resection|PROCEDURE: Gonadal vein embolization with coils|PROCEDURE: Endovascular stenting of the common iliac vein (CIV)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Comparative Effects of Two Procedures for the Management of Posterior Shoulder Tightness
Status: UNKNOWN
Conditions: Posterior Shoulder Tightness
Interventions: OTHER: Cross-body stretch (CBS)|OTHER: Mobilisation with movement (MWM)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
Status: COMPLETED
Conditions: Primary Insomnia
Interventions: DRUG: PD 0200390|DRUG: PD 0200390|DRUG: PD 0200390|DRUG: PD 0200390|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Compare 2 Formulations of LY900014 in Healthy Participants
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: LY900014-U200|DRUG: LY900014-U100
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Sex Difference Effects on Postoperative Sleep, Inflammation and Cognition in Patients Undergoing General Anesthesia
Status: UNKNOWN
Conditions: Sex Differences|Postoperative Sleep Quality|Postoperative Pain|Inflammation Function|Postoperative Cognitive Function
Interventions: OTHER: Video-Assisted Thoracoscopic Surgery
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)
Status: COMPLETED
Conditions: Lymphoma
Interventions: DRUG: Rituximab|DRUG: Ibritumomab tiuxetan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Dexmedetomidine and Magnesium Sulfate in Preventing Junctional Ectopic Tachycardia After Pediatric Cardiac Surgery
Status: COMPLETED
Conditions: Post Operative Arrythmia
Interventions: DRUG: Dexmedetomidine|DRUG: Magnesium sulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)
Status: COMPLETED
Conditions: Bacterial Vaginosis
Interventions: DRUG: DARE-BV1clindamycin phosphate vaginal gel, 2%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
Status: NOT_YET_RECRUITING
Conditions: Hepatocellular Carcinoma
Interventions: DRUG: Valemetostat|DRUG: Atezolizumab|DRUG: Bevacizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules
Status: UNKNOWN
Conditions: Gastrointestinal Stromal Tumor
Interventions: OTHER: DNA extraction of tumer tissue samples and high-throughput sequencing of small panels|OTHER: DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels|OTHER: DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
Status: COMPLETED
Conditions: Myasthenia Gravis|Ocular Myasthenia Gravis
Interventions: DRUG: Apraclonidine Hcl 0.5% Oph Soln
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Nasal Desmopressin Versus Oral Bisoprolol for Controlling Bleeding During Endoscopic Sinus Surgery
Status: COMPLETED
Conditions: Bleeding
Interventions: DRUG: nasal Desmopressin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety of L1-79 in Adolescent and Adult Males With Autism
Status: COMPLETED
Conditions: Autism
Interventions: DRUG: L1-79|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Status: TERMINATED
Conditions: Adult Liposarcoma|Recurrent Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
Interventions: DRUG: nelfinavir mesylate|PROCEDURE: biopsy|OTHER: laboratory biomarker analysis|OTHER: pharmacological study|GENETIC: gene expression analysis|GENETIC: western blotting|GENETIC: reverse transcriptase-polymerase chain reaction|OTHER: immunoenzyme technique
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA
Status: NOT_YET_RECRUITING
Conditions: Aplastic Anemia|Transfusion-dependent Anemia
Interventions: DRUG: rhTPO|DRUG: Cyclosporin A
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: RIPT of Ibuprofen Topical Gel
Status: COMPLETED
Conditions: Pain
Interventions: DRUG: Topical gel vehicle|DRUG: Topical gel vehicle|DRUG: Sodium lauryl sulfate 0.1%|DRUG: Sodium chloride solution 0.9% (saline)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: 30g vs 33g Needle for Intravitreal Injections
Status: COMPLETED
Conditions: Age Related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion
Interventions: PROCEDURE: Varying needle size with intravitreal ranibizumab or aflibercept
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effects of Light Emitting Diode Irradiation on the Conduction Parameters of the Superficial Radial Nerve
Status: COMPLETED
Conditions: Peripheral Neuropathy
Interventions: DEVICE: Superluminous light diode
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose:
Clinical trial: Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
Status: UNKNOWN
Conditions: Microvascular Angina
Interventions: DRUG: ticagrelor
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss
Status: RECRUITING
Conditions: Overweight|Obesity
Interventions: BEHAVIORAL: Coach Share On|BEHAVIORAL: Group Share On|BEHAVIORAL: Friend/Family Share On|BEHAVIORAL: Coach Share Off|BEHAVIORAL: Group Share Off|BEHAVIORAL: Friend/Family Share Off|BEHAVIORAL: Behavioral Weight Loss Treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of the Compression Belt for Patients With Sacroiliac Joint Pain
Status: COMPLETED
Conditions: Low Back Pain
Interventions: BEHAVIORAL: Lumbopelvic stabilization exercise|DEVICE: Sacroiliac joint belt
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.
Status: RECRUITING
Conditions: Sickle Cell Crisis
Interventions: DRUG: Sufentanil|DRUG: EMONO
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ventilation Distribution After Bariatric Surgery
Status: COMPLETED
Conditions: Bariatric Surgery Candidate|Atelectasis, Postoperative Pulmonary
Interventions: DEVICE: High flow nasal cannula|DEVICE: Continuous positive airway pressure|DEVICE: Facemask
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Pesticide and Pharmaceutical Contaminants Levels in Placenta and Cord Blood Samples of Pregnant Women With Fetal Growth Retardation and Healthy Pregnant Women
Status: UNKNOWN
Conditions: Fetal Growth Retardation
Interventions: OTHER: . Pesticide and Pharmaceutical analysis
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effect of the Combined Programme on Perioperative Anaemia（CPPA）
Status: RECRUITING
Conditions: Patient Blood Management|Cardiac Surgery|Iron Deficiency Anemia
Interventions: DRUG: Iron Sucrose, recombinant human erythropoietin, ascorbic acid|DRUG: saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Neuroblastoma
Interventions: DRUG: Sorafenib|DRUG: Cyclophosphamide|DRUG: Topotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Status: COMPLETED
Conditions: Brain Cancer|Arthritis, Rheumatoid|Central Nervous System Neoplasms|Glioma
Interventions: RADIATION: [18F]FHBG
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Percoffedrinol®|DRUG: Coumadin®|DRUG: Antra MUPS®|DRUG: Midazolam-ratiopharm®|DRUG: BI 730357
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)
Status: COMPLETED
Conditions: Rhinitis, Allergic, Perennial
Interventions: DRUG: Ciclesonide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery
Status: COMPLETED
Conditions: Postoperative Pain
Interventions: DRUG: Neostigmine|DRUG: ketamine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - Safety
Status: COMPLETED
Conditions: Hygiene
Interventions: DRUG: Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome
Status: WITHDRAWN
Conditions: Subacromial Impingement Syndrome|Subacromial Bursitis
Interventions: DRUG: Ketorolac|DRUG: Triamcinolone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
Status: NOT_YET_RECRUITING
Conditions: Coronary Artery Disease
Interventions: DRUG: Lansoprazole 15 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Abraxane and Alimta in Advanced Solid Tumors
Status: TERMINATED
Conditions: Breast Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: Abraxane|DRUG: Alimta
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors
Status: UNKNOWN
Conditions: Gastro-entero-pancreatic Neuroendocrine Tumors
Interventions: DRUG: Capecitabine|DRUG: Lu-PRRT|DRUG: SS-LAR
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effects of Conventional Exercise Combined With Core Stabilization Exercise by Telerehabilitation in Patients With Hip and/or Knee Osteoarthritis
Status: COMPLETED
Conditions: Hip Osteoarthritis|Knee Osteoarthritis
Interventions: OTHER: Conventional Exercise + Core Stabilization Exercise|OTHER: Conventional Exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effectiveness on an Application-Based Lifestyle Change Program on Health in Women
Status: COMPLETED
Conditions: Body Image|Self Esteem|Weight Loss|Health Behavior|Health-Related Behavior|Health Knowledge, Attitudes, Practice
Interventions: OTHER: FASTer Way Intervention|OTHER: Control Group Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT